moxifloxacin kabi 400 mg/250 ml infúzny roztok
fresenius kabi s.r.o., Česká republika - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
moxifloxacin msn
vivanta generics s.r.o., Česká republika - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
moxifloxacin olikla 5 mg/ml očné roztokové kvapky
olikla s.r.o., Česká republika - moxifloxacín - 64 - ophthalmologica
scemblix
novartis europharm limited - asciminib hydrochloride - leukémia, myelogénna, chronická, bcr-abl pozitívna - antineoplastické činidlá - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukémia, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
avelox 400
bayer ag - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
avelox 400 mg/250 ml infúzny roztok
bayer ag, nemecko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
moloxin 400 mg/250 ml infúzny roztok
krka, d.d., novo mesto, slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
moloxin 400 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
kimoks 400 mg filmom obalené tablety
alkaloid - int d.o.o., slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)